Xylem Inc. Investigation - XYL

Company
Xylem Inc. (NYSE: XYL)

Learn more about the Xylem Inc. Investigation

Required Field

Required Field

Required Field

  • $1 - $1,000
  • $1001 - $10,000
  • $10,001 - $25,000
  • $25,001 - $50,000
  • $50,001 - $100,000
  • $100,001 - $250,000
  • $250,001 - $500,000
  • $500,000+

There is no cost or obligation for you to submit.

The submission of this form does not create an attorney-client relationship.

Please Upload related files below

Add Transactions

Purchases

1.
  • Common Stock
  • Preferred Stock
  • Bonds
  • Calls
  • Puts
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12

Additional Purchases

Sales

1.
  • Common Stock
  • Preferred Stock
  • Bonds
  • Calls
  • Puts
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12

Additional Sales

Please input at least 1 transaction or press "skip for now" button below

Please fill in all the fields for your transaction or press "skip for now" button below

Alternatively, you may upload your transactions below or e-mail them to [email protected]

Upload Your Stock Tickers

Tell us the stocks you own using SnapTrade, and we will keep you informed about class action litigation related to your stocks. We monitor critical case developments that may affect the price of your shares and your possible monetary recovery. SnapTrade only shares the tickers you own and your transaction history, not your account numbers. Using SnapTrade and participating in our monitoring service is free and does not create any attorney-client relationship or obligation on your part.

Don’t miss out on possible monetary recovery - link your brokerage account with SnapTrade.

Skip

Xylem Inc. Investigation Details

Xylem Inc. shareholders lost money on October 27, 2026 when the stock fell after the Company reported third-quarter financial results that missed estimates and reduced its full-year performance outlook. For the third quarter of 2026, the Company reported revenue of approximately $2.20 billion compared to estimates of roughly $2.28 billion, and adjusted earnings per share of $1.44 compared to analyst estimates of $1.45-$1.46. Xylem Inc. reduced its full-year 2026 revenue outlook by roughly $700 million to $8.95 billion and cut its adjusted earnings per share guidance range to $5.40-$5.45 from its prior outlook of $5.55-$5.70. The previous EPS range had been elevated the previous quarter and subsequently reaffirmed when a new Chief Financial officer was appointed on August 18, 2026. The investigation concerns whether Xylem Inc. adequately disclosed project delays and cautious customer spending risks ahead of its earnings guidance reduction on October 27, 2026.

Get Started